An Update on the PDE-5 Inhibitors (PDE-5i)-Reference-Cited by-同舟云学术

An Update on the PDE-5 Inhibitors (PDE-5i)

Published:2003-11-12 Issue:S6 Volume:24 Page:S52-S58
ISSN:0196-3635
Container-title:Journal of Andrology
language:en
Short-container-title:

Author:

McCullough Andrew R.

Publisher

Wiley

Subject

Urology,Endocrinology,Reproductive Medicine,Endocrinology, Diabetes and Metabolism

Reference12 articles.

1. Selectivity of sildenafil and other phosphodiesterase type 5 (PDE5) inhibitors against human phosphodiesterase types 7-11;Baxendale;J Clin Pharmacol,2001

2. Human PDE-11: a distinct, dual substrate phosphodiesterase expressed in vascular smooth muscle and cardiac myocytes;Baxendale;Circulation,2000

3. Cyclic nucleotide phosphodiesterases:functional implications of multiple isoforms;Beavo;Physiol Rev,1995

4. Pharmacology of phophodiesterase-5 inhibitors;Corbin;Int J Clin Pract,2002

5. Sexual habits in the UK;Eardley;Int J Imp Res,2002

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Phosphodiesterase (PDE) 5 inhibitors sildenafil, tadalafil and vardenafil impact cAMP-specific PDE8 isoforms-linked second messengers and steroid production in a mouse Leydig tumor cell line;Molecular and Cellular Endocrinology;2022-02

2. Dihydrotestosterone (DHT) rapidly increase after maximal aerobic exercise in healthy males: the lowering effect of phosphodiesterase’s type 5 inhibitors on DHT response to exercise-related stress;Journal of Endocrinological Investigation;2020-09-18

3. Extending the use of tadalafil scaffold: Development of novel selective phosphodiesterase 5 inhibitors and histone deacetylase inhibitors;Bioorganic Chemistry;2020-05

4. Isolation and characterisation of a novel sildenafil analogue adulterant, desmethylpiperazinyl propoxysildenafil, in a dietary supplement;Science & Justice;2018-11

5. Pharmacophore and molecular docking based identification of novel structurally diverse PDE-5 inhibitors;Medicinal Chemistry Research;2014-07-20